97
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Altered BDNF Methylation in Patients with Chronic Musculoskeletal Pain and High Biopsychosocial Complexity

, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1289-1296 | Published online: 02 Jun 2020

References

  • Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129–136. doi:10.1126/science.847460
  • Melchert TP. 1 - the Need for a Unified Conceptual Framework in Professional Psychology. Elsevier; 2011.
  • Pincus T, Burton AK, Vogel S, Field AP. A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain. Spine (Phila Pa 1976). 2002;27(5):E109–120. doi:10.1097/00007632-200203010-00017
  • Marcoux V, Chouinard MC, Diadiou F, Dufour I, Hudon C. Screening tools to identify patients with complex health needs at risk of high use of health care services: a scoping review. PLoS One. 2017;12(11):e0188663. doi:10.1371/journal.pone.0188663
  • Luthi F, Stiefel F, Gobelet C, Rivier G, Deriaz O. Rehabilitation outcomes for orthopaedic trauma individuals as measured by the INTERMED. Disabil Rehabil. 2011;33(25–26):2544–2552. doi:10.3109/09638288.2011.579223
  • Scerri M, de Goumoens P, Fritsch C, Van Melle G, Stiefel F, So A. The INTERMED questionnaire for predicting return to work after a multidisciplinary rehabilitation program for chronic low back pain. Joint Bone Spine. 2006;73(6):736–741. doi:10.1016/j.jbspin.2005.12.012
  • Vouilloz A, Deriaz O, Rivier G, Gobelet C, Luthi F. Biopsychosocial complexity is correlated with psychiatric comorbidity but not with perceived pain in complex regional pain syndrome type 1 (algodystrophy) of the knee. Joint Bone Spine. 2011;78(2):194–199. doi:10.1016/j.jbspin.2010.07.006
  • Stiefel FC, de Jonge P, Huyse FJ, et al. INTERMED–an assessment and classification system for case complexity. Results in patients with low back pain. Spine (Phila Pa 1976). 1999;24(4):378–384. doi:10.1097/00007632-199902150-00017
  • Fischer CJ, Stiefel FC, De Jonge P, et al. Case complexity and clinical outcome in diabetes mellitus. A prospective study using the INTERMED. Diabetes Metab. 2000;26(4):295–302.
  • Hoogervorst EL, de Jonge P, Jelles B, et al. The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment. J Neurol Neurosurg Psychiatry. 2003;74(1):20–24. doi:10.1136/jnnp.74.1.20
  • Stiefel FC, de Jonge P, Huyse FJ, et al. “INTERMED”: a method to assess health service needs. II. Results on its validity and clinical use. Gen Hosp Psychiatry. 1999;21(1):49–56. doi:10.1016/S0163-8343(98)00061-9
  • Sabari BR, Zhang D, Allis CD, Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol. 2017;18(2):90–101. doi:10.1038/nrm.2016.140
  • Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6–21. doi:10.1101/gad.947102
  • Sato F, Tsuchiya S, Meltzer SJ, Shimizu K. MicroRNAs and epigenetics. FEBS J. 2011;278(10):1598–1609. doi:10.1111/j.1742-4658.2011.08089.x
  • Kerr JI, Burri A. Genetic and epigenetic epidemiology of chronic widespread pain. J Pain Res. 2017;10:2021–2029. doi:10.2147/JPR.S143869
  • Pradhan AA, Tipton AF, Zhang H, Akbari A, Pandey SC. Effect of histone deacetylase inhibitor on ethanol withdrawal-induced hyperalgesia in rats. Int J Neuropsychopharmacol. 2019;22(8):523–527. doi:10.1093/ijnp/pyz031
  • Bruehl S, Gamazon ER, Van de Ven T, et al. DNA methylation profiles are associated with complex regional pain syndrome following traumatic injury. Pain. 2019;160(10):2328–2337. doi:10.1097/j.pain.0000000000001624
  • Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–15. doi:10.1016/j.pain.2010.09.030
  • den Boer C, Dries L, Terluin B, et al. Central sensitization in chronic pain and medically unexplained symptom research: a systematic review of definitions, operationalizations and measurement instruments. J Psychosom Res. 2019;117:32–40. doi:10.1016/j.jpsychores.2018.12.010
  • Foltran RB, Diaz SL. BDNF isoforms: a round trip ticket between neurogenesis and serotonin? J Neurochem. 2016;138(2):204–221. doi:10.1111/jnc.13658
  • Chiba S, Numakawa T, Ninomiya M, Richards MC, Wakabayashi C, Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):112–119. doi:10.1016/j.pnpbp.2012.05.018
  • Nijs J, Meeus M, Versijpt J, et al. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets. 2015;19(4):565–576. doi:10.1517/14728222.2014.994506
  • Sosanya NM, Garza TH, Stacey W, Crimmins SL, Christy RJ, Cheppudira BP. Involvement of brain-derived neurotrophic factor (BDNF) in chronic intermittent stress-induced enhanced mechanical allodynia in a rat model of burn pain. BMC Neurosci. 2019;20(1):17. doi:10.1186/s12868-019-0500-1
  • Tao W, Chen Q, Zhou W, Wang Y, Wang L, Zhang Z. Persistent inflammation-induced up-regulation of brain-derived neurotrophic factor (BDNF) promotes synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluA1 subunits in descending pain modulatory circuits. J Biol Chem. 2014;289(32):22196–22204. doi:10.1074/jbc.M114.580381
  • Thomas M, Knoblich N, Wallisch A, et al. Increased BDNF methylation in saliva, but not blood, of patients with borderline personality disorder. Clin Epigenetics. 2018;10(1):109. doi:10.1186/s13148-018-0544-6
  • Kang HJ, Kim JM, Bae KY, et al. Longitudinal associations between BDNF promoter methylation and late-life depression. Neurobiol Aging. 2015;36(4):1764 e1761–1764 e1767. doi:10.1016/j.neurobiolaging.2014.12.035
  • Ferrer A, Labad J, Salvat-Pujol N, et al. BDNF genetic variants and methylation: effects on cognition in major depressive disorder. Transl Psychiatry. 2019;9(1):265. doi:10.1038/s41398-019-0601-8
  • Keller S, Sarchiapone M, Zarrilli F, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry. 2010;67(3):258–267. doi:10.1001/archgenpsychiatry.2010.9
  • Kim J-M, Kang H-J, Kim S-Y, et al. BDNF promoter methylation associated with suicidal ideation in patients with breast cancer. Int J Psychiatry Med. 2015;49(1):75–94. doi:10.1177/0091217415574439
  • Thaler L, Gauvin L, Joober R, et al. Methylation of BDNF in women with bulimic eating syndromes: associations with childhood abuse and borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:43–49. doi:10.1016/j.pnpbp.2014.04.010
  • Moser DA, Paoloni-Giacobino A, Stenz L, et al. BDNF methylation and maternal brain activity in a violence-related sample. PLoS One. 2015;10(12):e0143427. doi:10.1371/journal.pone.0143427
  • Unternaehrer E, Meyer AH, Burkhardt SC, et al. Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women. Stress. 2015;18(4):451–461. doi:10.3109/10253890.2015.1038992
  • Stenz L, Zewdie S, Laforge-Escarra T, et al. BDNF promoter I methylation correlates between post-mortem human peripheral and brain tissues. Neurosci Res. 2015;91:1–7. doi:10.1016/j.neures.2014.10.003
  • Ciampi de Andrade D, Maschietto M, Galhardoni R, et al. Epigenetics insights into chronic pain: DNA hypomethylation in fibromyalgia-a controlled pilot-study. Pain. 2017;158(8):1473–1480. doi:10.1097/j.pain.0000000000000932
  • Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23(2):129–138.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
  • Kori SH, Miller RP, Todd DD. Kinesiophobia: a new view of chronic pain behavior. Pain Manag. 1990;(3):35–43.
  • Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–532. doi:10.1037/1040-3590.7.4.524
  • Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622–626. doi:10.1111/j.1532-5415.1968.tb02103.x
  • Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1–2):29–36. doi:10.1016/j.pain.2004.12.010
  • Huyse FJ, Lyons JS, Stiefel FC, et al. “INTERMED”: a method to assess health service needs. I. Development and reliability. Gen Hosp Psychiatry. 1999;21(1):39–48. doi:10.1016/S0163-8343(98)00057-7
  • Luthi F, Deriaz O, Vuistiner P, Burrus C, Hilfiker R, Karniel A. Predicting non return to work after orthopaedic trauma: the Wallis Occupational Rehabilitation RisK (WORRK) model. PLoS One. 2014;9(4):e94268. doi:10.1371/journal.pone.0094268
  • Tuscher J, Burrus C, Vuistiner P, Leger B, Rivier G, Luthi F. Predictive value of the fear-avoidance model on functional capacity evaluation. J Occup Rehabil. 2018;28(3):513–522. doi:10.1007/s10926-017-9737-7
  • Louwies T, Ligon CO, Johnson AC, Greenwood-van Meerveld B. Targeting epigenetic mechanisms for chronic visceral pain: a valid approach for the development of novel therapeutics. Neurogastroenterol Motil. 2019;31(3):e13500. doi:10.1111/nmo.13500
  • Rustad SR, Papale LA, Alisch RS. DNA methylation and hydroxymethylation and behavior. Curr Top Behav Neurosci. 2019;42:51–82. doi:10.1007/7854_2019_104